Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
2.995
-0.025 (-0.83%)
At close: Jan 14, 2025, 4:00 PM
2.911
-0.084 (-2.81%)
After-hours: Jan 14, 2025, 5:59 PM EST
Aadi Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aadi Bioscience stock has a target of 1.75, which predicts a decrease of -41.57% from the current stock price of 3.00.
Analyst Consensus: Hold
* Price targets were last updated on Aug 27, 2024.
Analyst Ratings
The average analyst rating for AADI stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $1.75 | Buy → Hold | Downgrades | $5 → $1.75 | -41.57% | Aug 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 21, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $5 | Buy | Maintains | $30 → $5 | +66.94% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
26.41M
from 24.35M
Increased by 8.43%
Revenue Next Year
27.84M
from 26.41M
Increased by 5.41%
EPS This Year
-1.93
from -2.44
EPS Next Year
-0.31
from -1.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 27.6M | 29.1M | 69.3M | |||
| Avg | 26.4M | 27.8M | 48.9M | |||
| Low | 25.0M | 26.3M | 29.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 13.4% | 10.1% | 149.0% | |||
| Avg | 8.4% | 5.4% | 75.7% | |||
| Low | 2.5% | -0.2% | 5.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.98 | -0.32 | -0.27 | |||
| Avg | -1.93 | -0.31 | -0.27 | |||
| Low | -1.85 | -0.29 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.